Publication | Closed Access

Regorafenib or rechallenge chemotherapy: which is more effective in the third-line treatment of metastatic colorectal cancer?

OncologyColorectal CancerMetastatic Colorectal CancerPharmacotherapySurgeryCancer TreatmentThird-line TreatmentMedicineRadiation OncologyRechallenge Chemotherapy